We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+14.34%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.11B
AUM Growth
+$508M
Cap. Flow
+$71.5M
Cap. Flow %
1.4%
Top 10 Hldgs %
29.75%
Holding
158
New
25
Increased
53
Reduced
18
Closed
16

Top Buys

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$46M
2
ANNX icon
Annexon
ANNX
+$41.6M
3
CTAS icon
Cintas
CTAS
+$41M
4
GTM
ZoomInfo Technologies
GTM
+$40.9M
5
FRLN
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
+$39.2M

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$53.4M
2
LII icon
Lennox International
LII
+$42.7M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$40.3M
4
SPLK
Splunk Inc
SPLK
+$39.6M
5
ZGNX
Zogenix, Inc.
ZGNX
+$32.7M

Sector Composition

Rank Sector Weight
1 Healthcare 40.89%
2 Technology 24.02%
3 Industrials 10.32%
4 Consumer Discretionary 8.24%
5 Communication Services 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HASI icon
51
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$35M 0.68%
826,900
-12,200
-1% -$455K
NBIX icon
52
Neurocrine Biosciences
NBIX
$18.7B
$34.6M 0.68%
360,200
+2,400
+0.7% +$278K
DDOG icon
53
Datadog
DDOG
$95.6B
$34.3M 0.67%
335,335
+6,335
+2% +$551K
SPLK
54
DELISTED
Splunk Inc
SPLK
$34.1M 0.67%
181,237
-198,763
-52% -$39.6M
TPTX
55
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$33.5M 0.66%
383,000
– –
IMVT icon
56
Immunovant
IMVT
$8.11B
$32.8M 0.64%
932,000
+306,050
+49% +$9.2M
VCYT icon
57
Veracyte
VCYT
$4.77B
$30.2M 0.59%
930,000
– –
NOVT icon
58
Novanta
NOVT
$4.95B
$29.8M 0.58%
282,492
+2,492
+0.9% +$263K
GBT
59
DELISTED
Global Blood Therapeutics, Inc.
GBT
$29.5M 0.58%
535,000
– –
ZNTL icon
60
Zentalis Pharmaceuticals
ZNTL
$350M
$28.8M 0.56%
911,416
-3,289
-0.4% -$115K
ROL icon
61
Rollins
ROL
$18.5B
$26.3M 0.51%
727,500
-231,000
-24% -$7.99M
LII icon
62
Lennox International
LII
$14.4B
$25.9M 0.51%
95,000
-160,000
-63% -$42.7M
KALA icon
63
KALA BIO
KALA
$13.6M
$25.9M 0.51%
1,381
– –
VMC icon
64
Vulcan Materials
VMC
$35.1B
$25.3M 0.5%
187,000
-211,400
-53% -$26.6M
TECX
65
Tectonic Therapeutic
TECX
$538M
$24.8M 0.49%
158,776
– –
CGNX icon
66
Cognex
CGNX
$10.4B
$23.4M 0.46%
359,000
– –
OKTA icon
67
Okta
OKTA
$24.4B
$23.1M 0.45%
108,000
– –
SWKS icon
68
Skyworks Solutions
SWKS
$9.4B
$23M 0.45%
157,977
+9,777
+7% +$1.36M
SMAR
69
DELISTED
Smartsheet Inc.
SMAR
$21.6M 0.42%
437,000
-676,000
-61% -$32.6M
KALV
70
DELISTED
KalVista Pharmaceuticals
KALV
$21.2M 0.41%
1,680,000
– –
CRNX icon
71
Crinetics Pharmaceuticals
CRNX
$8.85B
$21.1M 0.41%
1,347,000
– –
AY
72
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$21.1M 0.41%
736,000
– –
MDB icon
73
MongoDB
MDB
$26.2B
$20.3M 0.4%
87,797
+1,797
+2% +$390K
SGEN
74
DELISTED
Seagen Inc. Common Stock
SGEN
$20.1M 0.39%
102,500
– –
STRO icon
75
Sutro Biopharma
STRO
$411M
$20M 0.39%
198,598
– –
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Eventide Asset Management held 158 positions worth $5.11B, up 11% from $4.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Eventide Asset Management's Q3 2020 filing shows 25 new, 53 increased, 18 reduced and 16 closed positions. Its largest new stake was Ecolab: 230,000 shares worth $46M. The largest sale was Aimmune Therapeutics, an estimated $53.4M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 45% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q3 2020 buy was Ecolab: 230,000 shares worth $46M.
  • Eventide Asset Management added most to Dynatrace in Q3 2020, an estimated $32.6M increase.
  • Eventide Asset Management's biggest Q3 2020 reduction was Lennox International, cutting an estimated $42.7M.
  • Eventide Asset Management fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $53.4M.
  • Eventide Asset Management's ten largest holdings make up 30% of its $5.11B portfolio in Q3 2020.
  • Eventide Asset Management opened 25 new positions and closed 16 in Q3 2020.
  • Eventide Asset Management's portfolio value rose 11% quarter-over-quarter to $5.11B.

Based on Eventide Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.